Catecholamine secretion and ploidy in phaeochromocytoma

International Journal of Clinical Practice

Volumn 54, Issue 8, 2000, Pages 520-523

  Tormey, W P ^a   Fitzgerald, R J ^a   Thomas, G ^a   Kay, E W ^a   Leader, M B ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CATECHOLAMINE; DNA; DOPAMINE; HOMOVANILLIC ACID; NORADRENALIN;

ARTICLE; CATECHOLAMINE RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; PHEOCHROMOCYTOMA; PLOIDY; PRIORITY JOURNAL;

ADRENAL GLAND NEOPLASMS; CATECHOLAMINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLOW CYTOMETRY; HOMOVANILLIC ACID; HUMANS; LACTATES; NEOPLASM RECURRENCE, LOCAL; PHEOCHROMOCYTOMA; PLOIDIES; PREDICTIVE VALUE OF TESTS; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL;

EID: 0033730230     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Drasin H. Treatment of malignant phaeochromocytoma. West J Med 1978: 128: 106-111.
2. Van Heerden JA, Sheps SG, Hamberger B el al. Phaeochromocytoma: current status and changing trends. Surgery 1982; 91: 367-373.
3. Scott HW Jr. Halter SA. Oncologic aspects of phaeochromocytoma: the importance of follow-up. Surgery 1984:96: 1061-1066.
4. Sparagana M. Late recurrence of benign pheochromocytomas: The necessity of long-term follow-up. J Surg Onctil 1988; 37: 140-146.
5. McMillan M. Identification of hydroxytyramine in a chromaffin tumour. Lancet I956;ii: 284.
6. Robinson R, Smith P. Whittaker SRF. Secretion of catecholamines in malignant phaeochromocytoma. BMJ 1964; 1: 1422-1424.
7. Von Studnitz W. Chemistry and pharmacology of catecholamine secreting tumors. Phimmicol Rev 1966; 18: 645-650.
8. Tippett PA, McEwan AJ, Ackery DM. A re-evaluation of dopamine excretion in phaeochromocytoma. din Endocrinol 1986; 25: 401-410.
9. Nativ O, Grant CS. Sheps SG et al. The clinical significance of nuclear DNA ploidy pattern in 184 patients with phaeochromocytoma. Cancer 1992:69: 2683-2687.
10. Nativ O. Grant CS, Sheps SG et al. Prognostic profile for patients with phaeochromocytoma derived from clinical and pathological factors and DNA ploidy pattern. J Surg Onco/ 1992; 50: 258-262.
11. Pang L-C, Tsao K-C. Flow cytometric DNA analysis for the determination of malignant potential in adrenal and extra-adrenal pheochromocytomas and paragangiomas. Arch Pathol Lah Med 1993; 117: 1142-1147.
12. Zhang XH, Wei SL, Wang FR et al. Studies on pathological morphology, clinical features and nuclear DNA contents by flow cytometry in adrenal neoplasms. Chinese Med J 1992; 105: 139-143.
13. Huang ST. Lai MK, Sun CC et al. Phaeochromocytoma nuclear pattern analysis by flow cytometry [Chinese]. Chang Keng i Hsuch die n g Gung MedJ 1993; 16: 188-192.
14. Lai MK, Sun CF, Chen CS et al. Deoxyribonucleic acid flow cytometric study in pheochromocytomas and its correlation with clinical parameters. Urology 1994;44: 185-188.
15. Sasagawa I, Nakada T, Kubota Y el al. Nuclear DNA ploidy pattern and tissue levels of dihydroxyphenylalanine and catecholamines in phaeochromocytoma. Urologia International 1995:54: 181-183.
16. Heaney AP, O'Rourke D, Arthur K et al. Flow cytometric analysis does not reliably differentiate benign from malignant phaeochromocytoma. Clin Endocrinol 1996; 44: 233-238.
17. Medley DW. Flow cytometry using paraffin-embedded tissue: Five years on. Cytometry 1989; 10: 229-241.
18. Leader MB. Kay EW, Barry Walsh CJ et al. Assessment of DNA ploidy: a review of methods and significance. Curr Diagnostic Pathol 1994; 1: 105-113.
19. Tormey WP. FitzGerald RF. Phaeochromocytoma - a laboratory experience. // J Med Sei 1995 ; 164: 142-145.
20. Lewis PD. A cytophotometric study of benign and malignant phaeochromocytomas. Virch Arch 1971: 9: 371-376.
21. Padberg BC, Achilles E. Garbe H el al. Histology, immumocytochemistry and DNA-cytophotometry of adrenal phaeochromocytoma (PCC) - a clinicomorphological study of 64 tumors. Verh Dtsch Gc.s Path 1990; 74: 389-394.
22. Proye C. Vix M, Goropoulos A et al. High incidence of malignant phaeochromocytoma in a surgical unit. 26 eases out of 100 patients operated from 1971 to 1991. J Endocrinol Invest 1992: 15: 651-663.
23. Hosaka Y, Rainwater LM, Grant CS et al. Phaeochromocytoma: nuclear deoxyribonucleic acid patterns studied by How cylotnetrv. Surger\ 1986: 100: 1003-1008.
24. Patterino F, Bouloux P-M. The diagnosis of malignancy in phaeochromocytoma. Clin Endocrinol 1996; 44: 239-241.
25. De Kruger RR. Van Der Harst E, Ver Der Ham F et al. Prognostic value of p53. bcl-2. and c-erbB-2 protein expression in phaeochromocytomas. J Pathol 1999; 188:51-55.
26. Cope C. Delbridge L. Philips J et al. Prognostic significance of nuclear DNA content in phaeochromocytoma. Aus! NZ J Surf; 1991: 61: 695-698.
27. Klein FA. Kay S, Ratliff JE et al. Flow cytometric determinations of ploidy and proliferation patterns of adrenal neoplasms: an adjunct to histological classification. J U ml 1985; 134: 862-866.
28. Amberson JB, Vaughan ED Jr, Gray GF et al. Flow cytometric determination of nuclear DNA content in benign adrenal pheochromocytomas. Urology 1987:30: 102-104.
29. Itakura H, Kinoshita K, Munakata A et al. Flow cytometric analysis of DNA aneuploidy in adrenal tumors. Jap J Ural 1992; 83: 53-58.
30. Jumg WH. Yang WI, Park C el al. DNA flow cytometry in phaeochromocytoma and paraganglioma. Yonsei Meil J 1992: 33: 249-257.
31. Gonzales-Camporra R, Dia/ Cano S. Lerma-Puertas E et al. Paragangliomas. Static cytometric studies of nuclear DNA patterns. Cancer 1993:71: 820-824.
32. Van Dekken H, Bosnian FT, Teijgeman R et al. Identification of numerical aberrations in archival tumors by in situ hybridization to routine paraffin sections: evaluation of 23 phaeochromocytomas ./ Pathol 1993; 171: 161-71.
33. Remmelink M, Salmon I, Pastecls JL et al. Nuclear DNA content, proliferation index and nuclear size determination in normal and tumoral adrenal tissues, pheochromocytomas and métastases. Ada Cytologica 1995; 39(31:416-422.